![Mark A. Gohr](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Mark A. Gohr
Finanzdirektor/CFO bei ANTH1, Inc.
Aktive Positionen von Mark A. Gohr
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Comptroller/Controller/Auditor | 17.06.2010 | - |
Finanzdirektor/CFO | 17.06.2010 | - | |
Direktor/Vorstandsmitglied | 17.07.2008 | 17.06.2010 |
Karriereverlauf von Mark A. Gohr
Ausbildung von Mark A. Gohr
The University of Colorado | Graduate Degree |
Hastings College | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 4 |
Operativ
Comptroller/Controller/Auditor | 1 |
Director/Board Member | 1 |
Director of Finance/CFO | 1 |
Sektoral
Consumer Services | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
ANTH1, Inc.
![]() ANTH1, Inc. Pharmaceuticals: MajorHealth Technology ANTH1, Inc. operates as a development stage company. It is a biotechnology company dedicated to developing vaccines for several infectious diseases including H5N1 influenza virus. The firm utilizes state of the art recombinant DNA adenoviral vector and Rnai (inhibition RNA) technologies to develop highly specific genetic vaccines. The company was founded on September 10, 2007 and is headquartered in Conifer, CO. | Health Technology |
- Börse
- Insiders
- Mark A. Gohr
- Erfahrung